{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:54:11Z","timestamp":1791302051218,"version":"4.1.0"},"reference-count":44,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Patients often experience travel-related barriers to methadone dosing at opioid treatment programs (OTPs), but the nature of their experiences are not well understood.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To characterize patient experiences with travel to OTPs for regular methadone dosing visits at a large multisite OTP in Washington state.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This qualitative study utilized an embedded mixed-methods design. Our sample included patients currently receiving methadone treatment at 2 OTP sites in Washington state from November 2024 to February 2026 (including mobile units that operated as extension of the sites). Data were analyzed between February and July 2026.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n Experiences of travel to OTPs for regular, in-person observed methadone dosing.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Results of a survey administered to patients regarding the modality, time, and cost (eg, gas, childcare) of traveling to the OTP. A subsample of surveyed patients were interviewed about their experiences with and perspectives on traveling for dosing visits. Survey data were analyzed descriptively. Interviews were coded using rapid assessment process.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Our sample included 98 survey participants and 16 qualitative interview participants (median [IQR] age, 43.0 [38.8-50.3] years; 8 cisgender women [50.0%]). Among survey respondents, 54 (55.1%) drove themselves to the OTP, 21 (21.4%) were driven by another person, 12 (12.3%) took public transportation, and 6 (6.1%) took insurer-sponsored medical transportation; 18 (18.4%) reported a disabling condition and 16 (16.2%) needed an assistive device for walking. Participants spent a mean (range) 82.5 (10.0-330.0) minutes round trip and $15.80 ($0-$200.00) in travel-related costs for each visit. Qualitative interviews illuminated that, while distance was often a barrier, unpredictable OTP wait times or conflicts with work, medical, or family obligations also mattered considerably. Participants shared that dosing visits directly prohibited their ability to work, but missing visits put participants at risk for return to opioid use and treatment stagnation.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this mixed-methods qualitative study, requiring regular visits for in-person observed methadone dosing presented significant structural barriers that affect patients\u2019 treatment experience, adherence, and lives. Increasing the flexibility and accessibility of methadone treatment\u2014through policies and novel care practices that actively seek to minimize burden of travel to the OTP and destigmatize care\u2014is essential to enhance care quality and equity.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.37601","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:00:19Z","timestamp":1791298819000},"page":"e2637601","source":"Crossref","is-referenced-by-count":0,"title":["Patient Travel Experiences for Methadone Dosing Visits"],"prefix":"10.1001","volume":"9","author":[{"given":"Elizabeth J.","family":"Austin","sequence":"first","affiliation":[{"name":"Division of General Internal Medicine, Department of Medicine, School of Medicine, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varuna","family":"Ravi","sequence":"additional","affiliation":[{"name":"Department of Health Systems and Population Health, School of Public Health, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"Gojic","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Department of Medicine, School of Medicine, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elenore P.","family":"Bhatraju","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Department of Medicine, School of Medicine, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Darnton","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Department of Medicine, School of Medicine, University of Washington, Seattle"},{"name":"Evergreen Treatment Services, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Grekin","sequence":"additional","affiliation":[{"name":"Evergreen Treatment Services, Seattle, Washington"},{"name":"Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Soth","sequence":"additional","affiliation":[{"name":"Evergreen Treatment Services, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Woolworth","sequence":"additional","affiliation":[{"name":"Evergreen Treatment Services, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin A.","family":"Hallgren","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith I.","family":"Tsui","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Department of Medicine, School of Medicine, University of Washington, Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily C.","family":"Williams","sequence":"additional","affiliation":[{"name":"Department of Health Systems and Population Health, School of Public Health, University of Washington, Seattle"},{"name":"Health Services Research & Development Center of Innovation for Veteran-Centered and Value-Driven Care, Veterans Affairs Puget Sound Health Care System, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"issue":"5","key":"zoi261013r1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11920-020-01149-0","article-title":"Identification and management of opioid use disorder in primary care: an update.","volume":"22","author":"Donroe","year":"2020","journal-title":"Curr Psychiatry Rep"},{"key":"zoi261013r3","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7325a1","article-title":"Treatment for opioid use disorder: population estimates\u2014United States, 2022.","volume":"73","author":"Deborah Dowell","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9","key":"zoi261013r4","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1007\/s10461-020-02887-1","article-title":"Rapid implementation of service delivery changes to mitigate COVID-19 and maintain access to methadone among persons with and at high-risk for HIV in an opioid treatment program.","volume":"24","author":"Peavy","year":"2020","journal-title":"AIDS Behav"},{"issue":"1","key":"zoi261013r5","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1080\/08897077.2022.2060438","article-title":"\u201cThe idea is to help people achieve greater success and liberty\u201d: a qualitative study of expanded methadone take-home access in opioid use disorder treatment.","volume":"43","author":"Suen","year":"2022","journal-title":"Subst Abus"},{"issue":"1","key":"zoi261013r6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s12954-024-01006-w","article-title":"\u201cIt didn\u2019t hurt me\u201d: patients\u2019 and providers\u2019 perspectives on unsupervised take-home doses, drug diversion, and overdose risks in the provision of medication for opioid use disorder during COVID-19 in San Juan, Puerto Rico.","volume":"21","author":"Abadie","year":"2024","journal-title":"Harm Reduct J"},{"issue":"1","key":"zoi261013r7","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1080\/08897077.2021.1986768","article-title":"COVID-19-related policy changes for methadone take-home dosing: a multistate survey of opioid treatment program leadership.","volume":"43","author":"Levander","year":"2022","journal-title":"Subst Abus"},{"issue":"S2","key":"zoi261013r8","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.2105\/AJPH.2021.306665","article-title":"The methadone manifesto: treatment experiences and policy recommendations from methadone patient activists.","volume":"112","author":"Simon","year":"2022","journal-title":"Am J Public Health"},{"key":"zoi261013r9","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2023.104302","article-title":"Adoption of methadone take home policy by U.S. state opioid treatment authorities during COVID-19.","volume":"124","author":"Roy","year":"2024","journal-title":"Int J Drug Policy"},{"issue":"2","key":"zoi261013r10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1097\/ADM.0000000000000841","article-title":"Permanent methadone treatment reform needed to combat the opioid crisis and structural racism.","volume":"16","author":"Peterkin","year":"2022","journal-title":"J Addict Med"},{"issue":"5","key":"zoi261013r11","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1097\/ADM.0000000000001459","article-title":"We drove to the moon: ensuring methadone access in rural Kentucky through peer transportation.","volume":"19","author":"Fallin-Bennett","year":"2025","journal-title":"J Addict Med"},{"issue":"1","key":"zoi261013r12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13722-022-00316-3","article-title":"Cumulative barriers to retention in methadone treatment among adults from rural and small urban communities.","volume":"17","author":"Pasman","year":"2022","journal-title":"Addict Sci Clin Pract"},{"issue":"2","key":"zoi261013r13","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1080\/10550887.2023.2165869","article-title":"Geographic variation in availability of opioid treatment programs across U.S. communities.","volume":"42","author":"Jehan","year":"2024","journal-title":"J Addict Dis"},{"issue":"13","key":"zoi261013r14","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1001\/jama.2019.12562","article-title":"Drive times to opioid treatment programs in urban and rural counties in 5 US states.","volume":"322","author":"Joudrey","year":"2019","journal-title":"JAMA"},{"issue":"4","key":"zoi261013r15","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.7028","article-title":"Assessment of community-level vulnerability and access to medications for opioid use disorder.","volume":"5","author":"Joudrey","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"2","key":"zoi261013r16","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.0209","article-title":"Accessibility of opioid treatment programs based on conventional vs perceived travel time measures.","volume":"7","author":"Kim","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"2","key":"zoi261013r18","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.57361","article-title":"Travel time to methadone treatment via personal vehicle vs public transit.","volume":"9","author":"Howell","year":"2026","journal-title":"JAMA Netw Open"},{"key":"zoi261013r19","doi-asserted-by":"publisher","DOI":"10.2196\/84162","article-title":"Acceptability of and implementation supports for video directly observed treatment to enhance methadone dosing flexibility in a multisite opioid treatment program: qualitative rapid needs assessment study.","volume":"10","author":"Tsui","year":"2026","journal-title":"JMIR Form Res"},{"key":"zoi261013r20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2022.108896","article-title":"Acceptability, feasibility, and outcomes of a clinical pilot program for video observation of methadone take-home dosing during the COVID-19 pandemic.","volume":"143","author":"Hallgren","year":"2022","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"zoi261013r21","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/hex.13384","article-title":"Pragmatism as a paradigm for patient-oriented research.","volume":"25","author":"Allemang","year":"2022","journal-title":"Health Expect"},{"issue":"1","key":"zoi261013r22","doi-asserted-by":"publisher","first-page":"82","DOI":"10.7748\/nr.12.1.82.s2","article-title":"Research design: qualitative, quantitative and mixed methods approaches.","volume":"12","author":"Twycross","year":"2004","journal-title":"Nurse Res"},{"issue":"5","key":"zoi261013r23","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s10488-013-0528-y","article-title":"Purposeful sampling for qualitative data collection and analysis in mixed method implementation research.","volume":"42","author":"Palinkas","year":"2015","journal-title":"Adm Policy Ment Health"},{"issue":"9","key":"zoi261013r24","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1097\/ACM.0000000000000388","article-title":"Standards for reporting qualitative research: a synthesis of recommendations.","volume":"89","author":"O\u2019Brien","year":"2014","journal-title":"Acad Med"},{"issue":"10","key":"zoi261013r26","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1177\/1049732320921835","article-title":"Rapid techniques in qualitative research: a critical review of the literature.","volume":"30","author":"Vindrola-Padros","year":"2020","journal-title":"Qual Health Res"},{"issue":"6","key":"zoi261013r28","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1370\/afm.1865","article-title":"Integrating quantitative and qualitative results in health science mixed methods research through joint displays.","volume":"13","author":"Guetterman","year":"2015","journal-title":"Ann Fam Med"},{"issue":"2","key":"zoi261013r30","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0740-5472(01)00185-4","article-title":"Transportation and retention in outpatient drug abuse treatment programs.","volume":"21","author":"Friedmann","year":"2001","journal-title":"J Subst Abuse Treat"},{"key":"zoi261013r31","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2025.101199","article-title":"A call to action to include disability in intersectional health equity research and policy.","volume":"49","author":"Havercamp","year":"2025","journal-title":"Lancet Reg Health Am"},{"issue":"2","key":"zoi261013r33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0317967","article-title":"Potential improvement in spatial accessibility of methadone treatment with integration into other outpatient substance use disorder treatment programs, New York City, 2024.","volume":"20","author":"Bachhuber","year":"2025","journal-title":"PLoS One"},{"issue":"3","key":"zoi261013r37","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jsat.2011.12.008","article-title":"Addiction treatment-related employment barriers: the impact of methadone maintenance.","volume":"43","author":"Richardson","year":"2012","journal-title":"J Subst Abuse Treat"},{"issue":"9","key":"zoi261013r38","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1176\/appi.ajp.2021.20101548","article-title":"Office-based methadone treatment for opioid use disorder and pharmacy dispensing: a scoping review.","volume":"178","author":"McCarty","year":"2021","journal-title":"Am J Psychiatry"},{"issue":"12","key":"zoi261013r39","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1111\/add.15087","article-title":"Global opioid agonist treatment: a review of clinical practices by country.","volume":"115","author":"Jin","year":"2020","journal-title":"Addiction"},{"issue":"4","key":"zoi261013r41","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1080\/00952990.2025.2525405","article-title":"Reducing stigma and expanding methadone access in the U.S.: the Modernizing Opioid Treatment Access Act and beyond.","volume":"51","author":"Nunes","year":"2025","journal-title":"Am J Drug Alcohol Abuse"},{"key":"zoi261013r42","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2026.105394","article-title":"Mobile but still tied down: challenges to scaling mobile methadone through a regulatory thicket.","volume":"155","author":"Krawczyk","year":"2026","journal-title":"Int J Drug Policy"},{"issue":"1","key":"zoi261013r43","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13011-022-00449-3","article-title":"Navigating intersecting public health crises: a qualitative study of people with opioid use disorders\u2019 experiences during the COVID-19 pandemic.","volume":"17","author":"Watson","year":"2022","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"zoi261013r27","doi-asserted-by":"crossref","DOI":"10.5040\/9798216417804","volume-title":"Rapid Assessment Process: An Introduction","author":"Beebe","year":"2001"},{"key":"zoi261013r32","volume-title":"Intersectionality","author":"Hill Collins","year":"2020","edition":"2nd ed"},{"key":"zoi261013r36","volume-title":"Dreamland: The True Tale of America\u2019s Opiate Epidemic","author":"Quinones","year":"2019"},{"key":"zoi261013r2","unstructured":"National Survey on Drug Use and Health. Accessed March 23, 2026. https:\/\/nsduhweb.rti.org\/respweb\/homepage.cfm"},{"key":"zoi261013r17","doi-asserted-by":"crossref","unstructured":"Plesons? M, Malecki? E, Ciraldo? K, . Accessibility of methadone treatment via public transit for syringe services program participants in Miami-Dade County, Florida.? Research Square. Preprint posted online August 27, 2024. doi:10.21203\/rs.3.rs-4791074\/v1","DOI":"10.21203\/rs.3.rs-4791074\/v1"},{"key":"zoi261013r25","unstructured":"American Association for Public Opinion Research. Disclosure standards. November 8, 2022. Accessed July 22, 2026. https:\/\/aapor.org\/standards-and-ethics\/disclosure-standards\/"},{"key":"zoi261013r29","unstructured":"US Centers for Disease Control and Prevention. Disability impacts all of us infographic. disability and health. May 20, 2026. Accessed May 27, 2026. https:\/\/www.cdc.gov\/disability-and-health\/articles-documents\/disability-impacts-all-of-us-infographic.html"},{"key":"zoi261013r34","unstructured":"Volkow? N. To address the fentanyl crisis, greater access to methadone is needed. National Institute on Drug Abuse blog. July 24, 2024. Accessed May 18, 2026. https:\/\/nida.nih.gov\/about-nida\/noras-blog\/2024\/07\/to-address-the-fentanyl-crisis-greater-access-to-methadone-is-needed"},{"key":"zoi261013r35","unstructured":"Facher? L. Rigid rules at methadone clinics are jeopardizing patients\u2019 path to recovery from opioid addiction. STAT News. March 12, 2024. Accessed May 18, 2026. https:\/\/www.statnews.com\/2024\/03\/12\/methadone-clinics-rigid-rules-opioid-addiction-recovery\/"},{"key":"zoi261013r40","unstructured":"Adams? Z, Krawczyk? N, Simon? R, Sue? K, Suen? LW, Joudrey? PL. To save lives from opioid overdose deaths, bring methadone into mainstream medicine. Health Affairs Forefront. May 27, 2022. Accessed May 18, 2026. https:\/\/www.healthaffairs.org\/do\/10.1377\/forefront.20220524.911965\/full\/"},{"key":"zoi261013r44","unstructured":"Heaps? W, Abrahmson? E, Skillen? E. Public transportation in the US: a driver of health and equity. HealthAffairs brief. Published online July 29, 2021. Accessed June 9, 2026. https:\/\/www.healthaffairs.org\/content\/briefs\/public-transportation-us-driver-health-and-equity"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2854876\/austin_2026_oi_261013_1790707327.34938.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:00:23Z","timestamp":1791298823000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2854876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":44,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.37601","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]}}}